Ledger.Open graph →
SEC Form D · filed December 23, 2015

EFFECTOR THERAPEUTICS, INC

Offering
$45.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Masaki Taniguchi · Grand Cayman, Cayman IslandsDirectorSimeon T. George · San Diego, CADirectorHenry C. Hansel · CHICAGO, ILExec · DirectorLaurence T. Lasky · San Diego, CADirectorStevan Rosenberg · Farmington Hills, MIExec · DirectorErik S. Nelson · CHICAGO, ILDirectorWilliam J. Duggan · Glastonbury, CTDirectorMichael Southworth · Palo Alto, CADirectorJonathan T. Root · San Diego, CADirectorKriss E. Spradley · CHICAGO, ILExecStephen T. Worland, Ph.D · San Diego, CAExec · DirectorAlana T. Mcnulty · San Diego, CAExecAmanda J. Forbes · HAMILTON, BermudaDirectorDavid T. Maki · San Diego, CADirectorStephen A. Zabawa · CHICAGO, ILDirectorThomas J. Bladek · Easton, CTDirectorAndrew J. Bresolin · CHICAGO, ILDirectorJohn G. Neal · HAMILTON, BermudaDirectorMarkus T. Goebel · San Diego, CADirectorKen T. Haas · San Diego, CADirectorRyan M. Gee · CHICAGO, ILDirectorRaymond T. Kish · CHICAGO, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗